SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VGNX -- Variagenics, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject7/11/2002 11:44:47 AM
From: Findit  Read Replies (1) of 269
 
Ridgeland, MS, JUL 11, 2002 (EventX/Knobias.com via COMTEX) -- Block Trade for: Variagenics (Nasdaq NM: VGNX)

Trade Time: 11:07 ET

Quoted: 1.12 x 1.15

Block Size: 865,000 --- 1,461.64% of 20-day ADSV (59,180)

Trade Price: $1.14

Dollar Value: $986,100 --- 3.731% of Marketcap $26,430,000

Volume @ Publication: 865,000 shares

GET KNOBIAS IN REAL-TIME: Delivery of this proprietary Knobias alert has been delayed by 10 minutes. To get all Knobias alerts in real-time daily, visit knobias.com

ABOUT KNOBIAS: Knobias is a financial information provider serving retail investors and trading professionals. Knobias collects and maintains real-time and historical market intelligence on all U.S. securities, with special emphasis on Over-the-Counter (OTC) stocks. Knobias provides customers with two core products: 1. Knobias FUNDAMENTALS: A comprehensive web-based database of fundamental research covering thousands of U.S. securities; 2. Knobias RAiDAR: A web-based desktop application that delivers thousands of real-time, intraday alerts daily. RAiDAR alerts include real-time news, filings, trading alerts, earnings alerts, coverage alerts and critical corp actions.

KNOBIAS DISCLAIMER: Knobias has received no compensation from the Company or Companies mentioned in this story. Knobias is not a registered broker-dealer, nor investment advisor, and does not endorse or recommend any securities mentioned. This story is provided for informational purposes only and is not intended for trading purposes. Knobias shall not be liable for any actions taken in reliance of any information provided herein. Republication or redistribution of Knobias content is expressly prohibited without prior written consent of Knobias.com, LLC.

CONTACT: Knobias.com, LLC 601-978-3399 601-978-3675 info@knobias.com www.knobias.com/cmtx

Copyright 2002 Knobias.com, LLC, All rights reserved.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext